Pharmaceutical

Fresenius Kabi and Cellular Origins agree CGT manufacture automation

Fresenius Kabi and Cellular Origins have announced a partnership to advance cell and gene therapy (CGT) by automating manufacturing.

Oct 18, 2024 - 04:00
Fresenius Kabi and Cellular Origins agree CGT manufacture automation
Fresenius Kabi and Cellular Origins have announced a partnership to advance cell and gene therapy (CGT) by automating manufacturing.
Read the original article

Tags:

Previous Article

Bavarian Nordic’s mpox vaccine equally effective in teens as adults

Next Article

Glaukos eyes FDA approval for ocular therapy after Phase III win

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

BMS gains EMA validation for Opdivo/Yervoy combo in liver cancer

BMS gains EMA validation for Opdivo/Yervoy combo in liv...

Jul 20, 2024

STAT+: CVS Health to close clinical trial unit two years after launch

STAT+: CVS Health to close clinical trial unit two year...

May 17, 2023

STAT+: Immunotherapy turned brain cancers from ‘cold’ to ‘hot’ in mouse study, as clinical trials advance

STAT+: Immunotherapy turned brain cancers from ‘cold’ t...

May 25, 2023